42 studies found for:    " September 14, 2011":" October 14, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Withdrawn Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women
Conditions: Pneumococcal Infections;   HIV Infections
Interventions: Biological: PPV-23 Vaccine;   Biological: PCV-13 Vaccine;   Biological: Placebo Vaccine
22 Completed Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract
Conditions: Women's Health;   HIV Infection;   Genital Diseases, Female
Intervention:
23 Unknown  Video-Based Delivery of HIV Test Information for Spanish-Speaking Latinos
Conditions: HIV;   AIDS
Intervention: Behavioral: Video or In-Person Presentation
24 Recruiting Bridges to the Future: Economic Empowerment for AIDS-Orphaned Children in Uganda
Conditions: Poverty;   Orphaned Children;   AIDS Orphans
Interventions: Behavioral: Bridges;   Behavioral: Bridges PLUS;   Other: Usual Care
25 Active, not recruiting Immunogenicity and Safety of HPV Vaccine in HIV-infected Pre-adolescent Girls and Boys in Kenya
Conditions: Human Papillomavirus;   HIV-1 Infection
Intervention: Biological: Gardasil vaccine
26 Recruiting Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS
Condition: HIV-1 Infection
Interventions: Drug: Coformulated EFV/FTC/TDF;   Drug: Etoposide;   Drug: Bleomycin and Vincristine (BV);   Drug: Doxorubicin HCL Liposome Injection (PLD)
27 Completed Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth
Conditions: HIV-1 Infection;   H1N1;   Influenza;   Flu
Interventions: Biological: FluMist;   Biological: Fluvirin;   Biological: Fluzone
28 Completed
Has Results
Rifaximin as a Modulator of Microbial Translocation and Immune Activation
Condition: HIV-1 Infection
Intervention: Drug: Rifaximin
29 Completed Promoting Male Involvement to Improve Prevention of Mother to Child Transmission (PMTCT) Uptake and Reduce Antenatal Infection
Conditions: HIV;   Pregnancy
Interventions: Behavioral: PartnerPlus Intervention;   Other: Usual Care
30 Completed A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV)
Condition: HIV
Interventions: Drug: Lopinavir ritonavir;   Drug: Atazanavir ritonavir;   Drug: Efavirenz
31 Recruiting A Key Link for Transmission Prevention
Condition: HIV
Interventions: Behavioral: Standard HIV prevention messages;   Behavioral: 5 counselor-delivered sessions;   Drug: ARVs with raltegravir and emtricitabine/tenofovir disoproxil fumarate
32 Enrolling by invitation Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments
Conditions: HIV;   Brain Tumors;   Neurofibromatosis 1
Intervention:
33 Completed Comparative Tolerability of Protease Inhibitors
Condition: HIV
Intervention:
34 Completed Obesity in HIV After Antiretroviral Therapy
Conditions: HIV;   AIDS;   Obesity
Intervention: Drug: antiretroviral therapy
35 Completed An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV Infection
Condition: Neoplasms
Intervention:
36 Recruiting Korean Post-marketing Surveillance for Reyataz®
Condition: HIV-1
Intervention: Drug: No Intervention
37 Terminated Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
Conditions: Hepatitis;   HIV/AIDS
Interventions: Drug: Boceprevir;   Drug: Peg-Interferon-alfa 2B;   Drug: Ribavirin
38 Recruiting Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM)
Condition: Amphetamine-Related Disorders
Interventions: Drug: extended-release naltrexone;   Drug: Placebo
39 Completed A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors
Condition: Solid Tumors
Interventions: Drug: Nelfinavir;   Drug: Nelfinavir Mesylate
40 Recruiting Tocilizumab for KSHV-Associated Multicentric Castleman Disease
Conditions: Castleman Disease;   Castleman's Disease;   Giant Lymph Node Hyperplasia
Interventions: Drug: Zidovudine;   Drug: Tocilizumab;   Drug: Valganciclovir

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results
Indicates status has not been verified in more than two years